Jun 6, 2019
The first wave of the opioid crisis began in 1991 when
physicians began to overprescribe narcotic analgesics for pain.
Eventually, addiction led to abuse and the fatality rates began to
climb. In response, the US government cracked down on narcotic
prescriptions--leading a surge in the price of medical grade
opioids. By 2010, the cost of pharmacologic opiates was
unaffordable, and users reverted back to the (now cheaper)
alternative, heroin. 2013 marked the third wave of the opioid
crisis, whereby synthetic, high-potency opiates like fentanyl and
carfentanyl were being infused into other opiate products. With
each wave, the world witnessed a spike in the number of
opioid-related deaths, and thus far, our solutions have only led to
new problems. But there is more to the opioid crisis than the
effect of opioids on the voluntary user.
In 2017, we released a show highlighting the clinical
consequences and management of opioid dependence on infants born to
mothers who had used opioids during their pregnancy. This week, we
have remastered the 2017 program and included an update at the
Produced by James E. Siegler. Music courtesy of Little Glass
Men, Jason Shaw, and Chris Zabriskie. BrainWaves' podcasts and
online content are intended for medical education only and should
not be used for clinical decision making. Be sure to follow us on
Twitter @brainwavesaudio for the latest updates to the podcast.
- McQueen K and Murphy-Oikonen J. Neonatal Abstinence Syndrome.
The New England journal of medicine.
- Vlahov D, Des Jarlais DC, Goosby E, Hollinger PC, Lurie PG,
Shriver MD and Strathdee SA. Needle exchange programs for the
prevention of human immunodeficiency virus infection: epidemiology
and policy. American journal of epidemiology.
- Kocherlakota P. Neonatal abstinence syndrome.
- Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S and
Alexander ER. Syringe exchange and risk of infection with hepatitis
B and C viruses. American journal of epidemiology.
- Wodak A and Cooney A. Do needle syringe programs reduce HIV
infection among injecting drug users: a comprehensive review of the
international evidence. Subst Use Misuse.
- Jarlenski M, Barry CL, Gollust S, Graves AJ, Kennedy-Hendricks
A and Kozhimannil K. Polysubstance Use Among US Women of
Reproductive Age Who Use Opioids for Nonmedical Reasons. Am J
Public Health. 2017;107:1308-1310.
- Hudak ML, Tan RC, Committee On D, Committee On F, Newborn and
American Academy of P. Neonatal drug withdrawal.
- Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM and
Patrick SW. Incidence and Costs of Neonatal Abstinence Syndrome
Among Infants With Medicaid: 2004-2014. Pediatrics.
- MacMillan KDL, Rendon CP, Verma K, Riblet N, Washer DB and
Volpe Holmes A. Association of Rooming-in With Outcomes for
Neonatal Abstinence Syndrome: A Systematic Review and
Meta-analysis. JAMA Pediatr. 2018;172:345-351.
- Gomez-Pomar E and Finnegan LP. The Epidemic of Neonatal
Abstinence Syndrome, Historical References of Its' Origins,
Assessment, and Management. Front Pediatr. 2018;6:33.